| Application no. and date | 17166616.7 (espacenet) (Federated) (European Patent Register), 20061027 | | Patent/reg. no. and date | DK/EP 3225233, 20190814 | | Publication date | 20171004 | | Priority no. and date | US 732221 P, 20051101 | | EP pub. no. and date |
EP 3225233 20171004 | | Effective date | | | Applicant/owner | Wyeth LLC, 235 East 42nd Street
New York, NY 10017-5755, US | | Applicant ref. no. | SH/GP/159201 | | Inventor | ZERFAS, Julie, 3 Stewart Road
Reading, MA 01867, US,
WEBB, Chandra A., 313 Gage Hill Road
Pelham, NH 03076, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 38/48 (2006.01) , A61K 47/02 (2006.01) , A61K 47/18 (2017.01) , A61K 47/26 (2006.01) , A61K 9/08 (2006.01) , A61K 9/19 (2006.01) | | Title | Natriumchloridopløsning til rekonstituering af lægemiddel | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2020 00004 | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
